Literature DB >> 9715357

Neuropsychological function in adults with attention-deficit hyperactivity disorder.

L J Seidman1, J Biederman, W Weber, M Hatch, S V Faraone.   

Abstract

BACKGROUND: Recent studies indicate that attention-deficit hyperactivity disorder (ADHD) persists into adulthood, but little is known about the neuropsychological features of adult ADHD. Our objective was to assess neuropsychological functioning in adults with ADHD with a battery of executive function tests.
METHODS: Subjects were 64 unmedicated adults, 19-59 years of age, with DSM-III-R ADHD of childhood onset who met criteria for ADHD when referred in adulthood and 73 non-ADHD controls of similar age and gender. Information on neuropsychological performance was obtained in a standardized manner blind to clinical status.
RESULTS: Compared with controls, adults with ADHD were significantly impaired on measures of vigilance, semantic encoding for verbal memory, and written arithmetic, irrespective of age, gender, psychiatric comorbidity, or presence of learning disability. Despite comparable educational level and IQ, ADHD adults had a trend to lower occupational attainment and had significantly more academic problems in school.
CONCLUSIONS: These executive, attention, and achievement dysfunctions demonstrated in adults with ADHD provide additional support for the validity of the syndrome in adults.

Entities:  

Mesh:

Year:  1998        PMID: 9715357     DOI: 10.1016/s0006-3223(97)00392-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  39 in total

Review 1.  Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

Authors:  Antonio Verdejo-García; Francisca López-Torrecillas; Carmen Orozco Giménez; Miguel Pérez-García
Journal:  Neuropsychol Rev       Date:  2004-03       Impact factor: 7.444

Review 2.  Subtypes of attention-deficit/hyperactivity disorder (ADHD): distinct or related disorders across measurement levels?

Authors:  Dieter Baeyens; Herbert Roeyers; Johan Vande Walle
Journal:  Child Psychiatry Hum Dev       Date:  2006

3.  Specificity of executive functioning and processing speed problems in common psychopathology.

Authors:  Joel T Nigg; Jennifer M Jester; Gillian M Stavro; Ka I Ip; Leon I Puttler; Robert A Zucker
Journal:  Neuropsychology       Date:  2017-01-16       Impact factor: 3.295

Review 4.  Raising attention to attention deficit hyperactivity disorder in schizophrenia.

Authors:  Stefano Pallanti; Luana Salerno
Journal:  World J Psychiatry       Date:  2015-03-22

5.  Methylphenidate-induced improvements of various measures of attention in adults with attention deficit hyperactivity disorder.

Authors:  O Tucha; L Mecklinger; R Laufkötter; H E Klein; S Walitza; K W Lange
Journal:  J Neural Transm (Vienna)       Date:  2006-08-08       Impact factor: 3.575

6.  Memory in early onset bipolar disorder and attention-deficit/hyperactivity disorder: similarities and differences.

Authors:  Anne H Udal; Bjørg Oygarden; Jens Egeland; Ulrik F Malt; Berit Groholt
Journal:  J Abnorm Child Psychol       Date:  2012-10

7.  Cognitive performance profiles by latent classes of drug use.

Authors:  P Truman Harrell; Brent Edward E Mancha; Silvia S Martins; Pia M Mauro; Julie H Kuo; Michael Scherer; Karen I Bolla; William W Latimer
Journal:  Am J Addict       Date:  2014-03-15

Review 8.  Assessment and management of attention-deficit hyperactivity disorder in adults.

Authors:  Margaret Weiss; Candice Murray
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

Review 9.  The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder.

Authors:  Stephen V Faraone
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-02       Impact factor: 4.785

10.  Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder.

Authors:  Danielle C Turner; Andrew D Blackwell; Jonathan H Dowson; Andrew McLean; Barbara J Sahakian
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.